Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Bach

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Translational Psychiatry|March 31, 2026
Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort studyPatrick Bach, Johan Franck, Jonas Hällgren, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 18, 2021
Reliability of the fMRI-based assessment of self-evaluation in individuals with internet gaming disorderPatrick Bach, Holger Hill, Iris Reinhard, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 12, 2025
Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorderPatrick Bach, Johan Franck, Jonas Hällgren, et al.
Acta Psychiatrica Scandinavica|March 17, 2025
Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol-Related Hospitalizations: A Register StudyPatrick Bach, Johan Franck, Jonas Hällgren, et al.
The Lancet Regional Health. Europe|April 6, 2026
Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational studyPatrick Bach, Johan Franck, Jonas Hällgren, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 25, 2021
Plasma calcium concentration during detoxification predicts neural cue-reactivity and craving during early abstinence in alcohol-dependent patientsPatrick Bach, Rilana Schuster, Anne Koopmann, et al.
Psychoneuroendocrinology|July 31, 2019
Oxytocin modulates alcohol-cue induced functional connectivity in the nucleus accumbens of social drinkersPatrick Bach, Iris Reinhard, Sina Bühler, et al.
European Addiction Research|August 28, 2025
Investigating decision-making under risk in pathological gambling using a virtual slot machine - a pilot eye-tracking studyGloria Baumann, Ronald Fischer, Iris Reinhard, et al.
Molecular Psychiatry|December 12, 2024
Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trialSina Zimmermann, Anton Teetzmann, Joscha Baeßler, et al.
Psychopharmacology|August 29, 2025
CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder - a randomized controlled trialMarlen Pfisterer, Anton Teetzmann, Sina Vetter, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Translational Psychiatry|March 31, 2026
Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort studyPatrick Bach, Johan Franck, Jonas Hällgren, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 18, 2021
Reliability of the fMRI-based assessment of self-evaluation in individuals with internet gaming disorderPatrick Bach, Holger Hill, Iris Reinhard, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 12, 2025
Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorderPatrick Bach, Johan Franck, Jonas Hällgren, et al.
Acta Psychiatrica Scandinavica|March 17, 2025
Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol-Related Hospitalizations: A Register StudyPatrick Bach, Johan Franck, Jonas Hällgren, et al.
The Lancet Regional Health. Europe|April 6, 2026
Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational studyPatrick Bach, Johan Franck, Jonas Hällgren, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 25, 2021
Plasma calcium concentration during detoxification predicts neural cue-reactivity and craving during early abstinence in alcohol-dependent patientsPatrick Bach, Rilana Schuster, Anne Koopmann, et al.
Psychoneuroendocrinology|July 31, 2019
Oxytocin modulates alcohol-cue induced functional connectivity in the nucleus accumbens of social drinkersPatrick Bach, Iris Reinhard, Sina Bühler, et al.
European Addiction Research|August 28, 2025
Investigating decision-making under risk in pathological gambling using a virtual slot machine - a pilot eye-tracking studyGloria Baumann, Ronald Fischer, Iris Reinhard, et al.
Molecular Psychiatry|December 12, 2024
Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trialSina Zimmermann, Anton Teetzmann, Joscha Baeßler, et al.
Psychopharmacology|August 29, 2025
CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder - a randomized controlled trialMarlen Pfisterer, Anton Teetzmann, Sina Vetter, et al.
Pageof 9